Related references
Note: Only part of the references are listed.Anthracycline-induced cardiotoxicity and renin-angiotensin-aldosterone system-from molecular mechanisms to therapeutic applications
Pawel Sobczuk et al.
HEART FAILURE REVIEWS (2022)
Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals
Chandrakala Aluganti Narasimhulu et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2022)
Divergent Cardiac Effects of Angiotensin II and Isoproterenol Following Juvenile Exposure to Doxorubicin
Kevin Agostinucci et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2022)
Molecular mechanisms of doxorubicin-induced cardiotoxicity: novel roles of sirtuin 1-mediated signaling pathways
Jie Wang(a) et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Combined Administration of Metformin and Atorvastatin Attenuates Diabetic Cardiomyopathy by Inhibiting Inflammation, Apoptosis, and Oxidative Stress in Type 2 Diabetic Mice
Weikun Jia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Serial Cardiovascular Magnetic Resonance Strain Measurements to Identify Cardiotoxicity in Breast Cancer Comparison With Echocardiography
Christian P. Houbois et al.
JACC-CARDIOVASCULAR IMAGING (2021)
Cardiac computed tomography-derived extracellular volume fraction in late anthracycline-induced cardiotoxicity
Koichi Egashira et al.
IJC HEART & VASCULATURE (2021)
MicroRNA-130a Increases and Predicts Cardiotoxicity during Adjuvant Chemotherapy in Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer
Qiang Feng et al.
JOURNAL OF BREAST CANCER (2021)
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils
Lauren A. Baldassarre et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)
Impact of Arterial Hypertension on Doxorubicin-Based Chemotherapy-Induced Subclinical Cardiac Damage in Breast Cancer Patients
Domas Vaitiekus et al.
CARDIOVASCULAR TOXICOLOGY (2020)
Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients
Hyunsoon Cho et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Breast Cancer, Version 3.2020
William J. Gradishar et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Astaxanthin Attenuates Hypertensive Vascular Remodeling by Protecting Vascular Smooth Muscle Cells from Oxidative Stress-Induced Mitochondrial Dysfunction
Yuqiong Chen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Analysing the risk factors of doxorubicin-associated heart failure by a retrospective study of integrated, nation-wide databases
Fogarassy Gyorgy et al.
ORVOSI HETILAP (2020)
Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial
Alexandra Maria Rueger et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Omentin protects H9c2 cells against docetaxel cardiotoxicity
Ricardo Lage et al.
PLOS ONE (2019)
Ibudilast attenuates doxorubicin-induced cytotoxicity by suppressing formation of TRPC3 channel and NADPH oxidase 2 protein complexes
Kazuhiro Nishiyama et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Doxorubicin induces trans-differentiation and MMP1 expression in cardiac fibroblasts via cell death-independent pathways
Masatoshi Narikawa et al.
PLOS ONE (2019)
Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress
Junxia Hu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Prediction of trastuzumab-induced cardiotoxicity in breast cancer patients receiving anthracycline-based chemotherapy
Wafaa S. El-Sherbeny et al.
JOURNAL OF ECHOCARDIOGRAPHY (2019)
Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy
Hai Li et al.
YONSEI MEDICAL JOURNAL (2019)
Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer
Amy A. Kirkham et al.
BMC CANCER (2018)
Ginsenoside Rg1 Prevents Doxorubicin-Induced Cardiotoxicity through the Inhibition of Autophagy and Endoplasmic Reticulum Stress in Mice
Zhi-Meng Xu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Effect of Breast Irradiation on Cardiac Disease in Women Enrolled in BCIRG-001 at 10-Year Follow-Up
S. Peter Wu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Cardioprotective Effect of Dexrazoxane in Patients with HER2-Positive Breast Cancer Who Receive Anthracycline Based Adjuvant Chemotherapy Followed by Trastuzumab
In-Ho Kim et al.
JOURNAL OF BREAST CANCER (2017)
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2
Patricia A. Ganz et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Western diet increases cardiac ceramide content in healthy and hypertrophied hearts
T. J. Butler et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2017)
The paradox of the first cycle of chemotherapy-transient improvement of contractility and diastolic function after the first cycle of anthracycline-based chemotherapy: a prospective clinical trial
Pawel Stachowiak et al.
ONCOTARGET (2017)
The incidence of cardiomyopathy in BRCA1 and BRCA2 mutation carriers after anthracycline-based adjuvant chemotherapy
Edward J. Pearson et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Risk factors for anthracycline-associated cardiotoxicity
Raquel E. Reinbolt et al.
SUPPORTIVE CARE IN CANCER (2016)
A Prospective Cohort Study on Cardiotoxicity of Adjuvant Trastuzumab Therapy in Breast Cancer Patients
Erika Matos et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA (2016)
Obesity As a Risk Factor for Anthracyclines and Trastuzumab Cardiotoxicity in Breast Cancer: A Systematic Review and Meta-Analysis
Charles Guenancia et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer
Paul Kotwinski et al.
PLOS ONE (2016)
Role of baseline echocardiography prior to initiation of anthracycline-based chemotherapy in breast cancer patients
Alain Mina et al.
BMC CANCER (2015)
Doxorubicin-induced cardiac dysfunction in unselected patients with a history of early-stage breast cancer
Megan E. V. Caram et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Sirtuin-3 (SIRT3) Protein Attenuates Doxorubicin-induced Oxidative Stress and Improves Mitochondrial Respiration in H9c2 Cardiomyocytes
Kyle G. Cheung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Diastolic Dysfunction Following Anthracycline-Based Chemotherapy in Breast Cancer Patients: Incidence and Predictors
Jose M. Serrano et al.
ONCOLOGIST (2015)
Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK
Xue Wang et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation
Yoshihiko Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Early Cardiac Function Monitoring for Detection of Subclinical Doxorubicin Cardiotoxicity in Young Adult Patients with Breast Cancer
Woo-Baek Chung et al.
JOURNAL OF BREAST CANCER (2013)
Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats
Leslie C. Sharkey et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Role of the renin-angiotensin-aldosterone system and the glutathione S-transferase Mu, Pi and Theta gene polymorphisms in cardiotoxicity after anthracycline chemotherapy for breast carcinoma
Daniela Vivenza et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2013)
Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines
G. Curigliano et al.
ANNALS OF ONCOLOGY (2012)
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Heloisa Sawaya et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism
Sonomi Maruyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial
Evandro de Azambuja et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the north central cancer treatment group n9831 adjuvant breast cancer trial
Edith A. Perez et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High fat diet-fed obese rats are highly sensitive to doxorubicin-induced cardiotoxicity
Mayurranjan S. Mitra et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2008)
Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity
Mayurranjan S. Mitra et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2007)
Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
Mary C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Trastuzumab treatment and the risk of central nervous system (CNS) metastases
M. C. Pinder et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Depletion of adenine nucleotide translocator protein in heart mitochondria from doxorubicin-treated rats- Relevance for mitochondrial. dysfunction
PJ Oliveira et al.
TOXICOLOGY (2006)
Activation of NADPH oxidase during progression of cardiac hypertrophy to failure
JM Li et al.
HYPERTENSION (2002)
Functional monitoring of anthracycline cardiotoxicity: a prospective, blinded, long-term observational study of outcome in 120 patients
BV Jensen et al.
ANNALS OF ONCOLOGY (2002)
Validation of the Framingham Coronary Heart Disease prediction scores - Results of a multiple ethnic groups investigation
RB D'Agostino et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension
G Schillaci et al.
HYPERTENSION (2000)
Effect of streptozotocin-induced hyperglycaemia on intravenous pharmacokinetics and acute cardiotoxicity of doxorubicin in rats
OA Al-Shabanah et al.
PHARMACOLOGICAL RESEARCH (2000)
Share Paper
